Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden · Delayed Price · Currency is SEK 0.7660
+0.0080 (1.06%)
May 4, 2026, 4:58 PM CET
Prostatype Genomics AB Market Cap
Prostatype Genomics AB has a market cap or net worth of 45.34 million as of May 4, 2026. Its market cap has increased by 37.44% in one year.
Market Cap
45.34M
Enterprise Value
36.27M
Revenue
594.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.77
Market Cap Chart
Since November 3, 2020, Prostatype Genomics AB's market cap has decreased from 92.30M to 45.34M, a decrease of -50.88%. That is a compound annual growth rate of -12.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 45.34M | 155.33% |
| Dec 30, 2025 | 17.76M | -76.14% |
| Dec 30, 2024 | 74.42M | 555.78% |
| Dec 29, 2023 | 11.35M | -76.58% |
| Dec 30, 2022 | 48.46M | -64.07% |
| Dec 30, 2021 | 134.89M | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 147.95B |
| Getinge AB | 49.99B |
| Sectra AB | 49.17B |
| Camurus AB | 31.73B |
| Nanologica AB | 64.07M |
| Qlife Holding AB | 60.68M |
| ScandiDos AB | 55.87M |
| Modus Therapeutics Holding AB | 49.87M |